← Evidence map

ReviewCurrent oncology reports2013

Foretinib (XL880): c-MET inhibitor with activity in papillary renal cell cancer.

Theodore F LoganPubMed ↗Publisher ↗

No numbers read from the abstract.

17 papers cite it

2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 23408121